ClinVar Miner

Submissions for variant NM_001282531.3(ADNP):c.2157C>G (p.Tyr719Ter)

dbSNP: rs587777526
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000190684 SCV000244124 pathogenic Inborn genetic diseases 2015-04-08 criteria provided, single submitter clinical testing
GeneDx RCV000483727 SCV000567157 pathogenic not provided 2022-06-20 criteria provided, single submitter clinical testing Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 384 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29724491, 25057125, 28407407, 28221363, 24531329, 29911927, 29475819, 31785789, 33004838, 32758449, 31526516)
Illumina Laboratory Services, Illumina RCV000128578 SCV002038512 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 2021-10-01 criteria provided, single submitter clinical testing The ADNP c.2157C>G (p.Tyr719Ter) variant is a stop-gained variant that is predicted to result in a premature termination or absence of the protein. This variant is located in the last exon and may escape nonsense-mediated decay. Across a selection of literature, the p.Tyr719Ter variant has been reported in a de novo heterozygous state in at least eight probands with a phenotype consistent with ADNP-related neurodevelopmental disorder (Helsmoortel et al. 2014; Pescosolido et al. 2014; Gozes et al. 2017). Van Dijck et al. 2019) noted that individuals with the p.Tyr719Ter variant walk later and have a higher pain threshold than individuals with other pathogenic ADNP variants. This variant is not found in version 2.1.1 or version 3.1.1 of the Genome Aggregation Database despite its location in a region of good sequencing coverage, which suggests the variant is rare. Based on the collective evidence, the p.Tyr719Ter variant is classified as pathogenic for ADNP-related neurodevelopmental disorder.
3billion RCV000128578 SCV002058509 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 2022-01-03 criteria provided, single submitter clinical testing Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10% (PVS1_S). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 29724491, 24531329, PS4_S) and reported as de novo in a similarly affected individual (PMID: 24531329, PS2_S). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000139635, PMID:24531329). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV000128578 SCV002768748 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 2020-05-25 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.1.0, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0204 - Variant is predicted to result in a truncated protein with more than 1/3 of the protein affected. (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0600 - Variant is located upstream of an annotated domain or motif (Homeodomain; NCBI, PDB). (N) 0701 - Comparable variants have very strong previous evidence for pathogenicity (ClinVar). (P) 0801 - Strong previous evidence of pathogenicity in unrelated individuals (ClinVar, Deciphering Developmental Disorders Study, Helsmoortel, C. et al. (2014)). (P) 1102 - Strong phenotype match. (P) 1203 - Variant shown to be de novo in proband (parental status confirmed). (P)
Invitae RCV000483727 SCV003443958 pathogenic not provided 2022-10-06 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 139635). This premature translational stop signal has been observed in individual(s) with Helsmoortel-van der Aa syndrome (PMID: 28221363, 28708303). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr719*) in the ADNP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 384 amino acid(s) of the ADNP protein.
Revvity Omics, Revvity RCV000128578 SCV003816653 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 2022-04-27 criteria provided, single submitter clinical testing
OMIM RCV000128578 SCV000172226 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 2014-09-01 no assertion criteria provided literature only
GeneReviews RCV000128578 SCV000267170 not provided ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder no assertion provided literature only Pathogenic variant in exon 4; associated with later onset of walking and higher pain threshold than other ADNP pathogenic variants
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille RCV000128578 SCV001427621 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 2019-01-01 no assertion criteria provided clinical testing
Pediatric Department, Xiangya Hospital, Central South University RCV000128578 SCV004032206 pathogenic ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.